Ronald Henry
Urology · Shenandoah, TXNPI 1306806088
Payments from drug & device makers
Across 207 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$770
- Astellas Pharma US Inc$739
- AbbVie$656
- Pfizer$521
- Antares Pharma, Inc.$323
- Endo Pharmaceuticals Inc.$234
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,74490%
- Education$53810%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 29 | $770 |
| Astellas Pharma US Inc | 25 | $739 |
| AbbVie(2 entities) | 36 | $656 |
| Pfizer | 23 | $521 |
| Antares Pharma, Inc. | 14 | $323 |
| Endo Pharmaceuticals Inc. | 13 | $234 |
| Sumitomo Pharma America, Inc. | 9 | $182 |
| Teleflex LLC | 3 | $179 |
| Axonics, Inc. | 6 | $169 |
| Myriad Genetic Laboratories, Inc. | 9 | $165 |
| Myovant Sciences Inc. | 2 | $152 |
| Coloplast | 1 | $149 |
| Novartis | 1 | $124 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $122 |
| Urogen Pharma, Inc. | 1 | $110 |
| Urovant Sciences Inc | 5 | $98 |
| Alnylam Pharmaceuticals Inc. | 3 | $74 |
| Bayer | 2 | $56 |
| Rochester Medical Corporation | 2 | $47 |
| Therapeuticsmd, Inc. | 2 | $44 |
| Halozyme Inc | 2 | $40 |
| Olympus America Inc. | 1 | $27 |
| Procept Biorobotics Corporation | 1 | $27 |
| Medtronic | 1 | $25 |
| Agiliti Surgical, Inc. | 1 | $24 |
| Telix Pharmaceuticals | 1 | $24 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $23 |
| Tolmar, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $22 |
| Travere Therapeutics, Inc. | 1 | $21 |
| Caris MPI, Inc. | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Merck | 1 | $18 |
| Hollister Incorporated | 1 | $17 |
| Dendreon Pharmaceuticals LLC | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $13 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,282 in reported general payments places this provider in the 55th percentile of 878 urology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 70 | $1,415 |
| Finasteride | 21 | $259 |
Paid to pharmacies, not to this prescriber.
Other urology in Shenandoah
- Zvi SchiffmanHouston$17.8M
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Jose KaramHouston$5.7M
- Daniel ZainfeldSan Antonio$4.7M
- Brian MazzarellaLakeway$4.5M
- Andrew von EschenbachMontgomery$3.2M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
- Homa PorterDallas$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.